Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.

Circulation

Volumn 109, Issue 25, 2004, Pages 3171-3175

  Matetzky, Shlomi ^a   Shenkman, Boris ^a   Guetta, Victor ^a   Shechter, Michael ^a   Bienart, Roy ^a   Goldenberg, Ilan ^a   Novikov, Ilya ^a   Pres, Hanna ^a   Savion, Naphtali ^a   Varon, David ^a   Hod, Hanoch ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; EPTIFIBATIDE; PEPTIDE; PRODRUG; PURINE P2 RECEPTOR; TICLOPIDINE;

AGED; ARTICLE; BIOTRANSFORMATION; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; RECURRENT DISEASE; RESTENOSIS; RISK; SMOKING; STENT; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

ADENOSINE DIPHOSPHATE; AGED; ASPIRIN; BIOTRANSFORMATION; COMBINED MODALITY THERAPY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPINEPHRINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PRODRUGS; PROSPECTIVE STUDIES; RECEPTORS, PURINERGIC P2; RECURRENCE; RISK; SMOKING; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 8344221349     PISSN: None     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/01.CIR.0000130846.46168.03     Document Type: Article

References (0)